• Profile
Close

Screening for colorectal cancer in the United States: Correlates and time trends by type of test

Cancer Epidemiology, Biomarkers & Prevention Jun 09, 2021

Shapiro JA, Soman AV, Berkowitz Z, et al. - Screening for colorectal cancer (CRC) is strongly recommended for adults aged 50-75 years. Colonoscopy, sigmoidoscopy, computed tomography colonography, guaiac fecal occult blood testing (FOBT), fecal immunochemical testing (FIT), or the more recently introduced FIT-DNA (FIT in combination with a stool DNA test) is the recommended screening options. Researchers sought to report on the CRC screening test used for adults aged 50-75 years (N = 10,595). In addition, they determined the time trends in CRC screening test use from 2010-2018. Within recommended time intervals, colonoscopy was the most commonly used test type within 10 years (61.1%), followed by FOBT or FIT in the past year (8.8%), and FIT-DNA within 3 years (2.7%). The percentage up-to-date with CRC screening rose from 61.2% in 2015 to 65.3% in 2018 after age-standardization to the 2010 census population; this was driven by increased use of stool testing, including FIT-DNA. Despite some progress due to a modest rise in stool testing, CRC testing remains low in many population subgroups.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay